Park Ha Biological Technology Co., Ltd. Faces Class Action Due to Stock Collapse Allegations

Investor Alert: Class Action Filed Against Park Ha Biological Technology Co., Ltd.

On September 3, 2026, SueWallSt announced a significant class action against Park Ha Biological Technology Co., Ltd., trading on NASDAQ with the ticker BYAH. The lawsuit pertains specifically to the alarming events surrounding the company's stock, which plummeted approximately 93% on July 8, 2025, erasing over $1 billion in market capitalization. This distressing collapse has triggered serious concerns among investors who purchased securities between December 27, 2024, and the date of the plunge.

Background Information

When Park Ha Biological Technology launched its Initial Public Offering (IPO), it set the stage for potential rapid stock fluctuations, indicating that low-float stocks might encounter extreme price volatility. However, the complaint alleges that the company failed to disclose critical information surrounding a grossly manipulated promotional scheme that predated the stock's dramatic decline.

According to SueWallSt, the stock faced an unprecedented drop, revealing a troubling narrative of a pump-and-dump scheme where impersonators masquerading as legitimate financial advisors used various platforms—including WhatsApp—to direct investors towards BYAH. Notably, fabricated claims of a partnership with L'Oréal and promises of enormous gains were used to lure retail investors, starting as early as June 18, 2025.

Key Allegations

The plaintiffs assert that Park Ha Biological Technology made misleading statements about its business viability, stating that:

1. Failure to disclose risk factors: While the IPO prospectus acknowledged potential stock volatility, it failed to recognize that the volatility was a reality impacting the shares at that moment. The suit claims that the company's generic risk factors concealed the already existing issues linked to the stock's manipulated trading.

2. Undisclosed public float: The class action highlights that the IPO, which only comprised 1,200,000 shares, left the public float shockingly low at under 5% of the 26,200,000 total shares outstanding, enabling dubious activities on modest trading volumes.

3. Insider control: The complaint emphasizes that insiders maintained more than 95% of the shares, which allegedly made dramatic price fluctuations on a low volume of trades feasible.

4. Lack of response to stock drop: After the shares skyrocketed from an IPO price of $4.00 to an intraday high of $41.49 just before collapsing, no warnings or press releases were issued by the company to address these alarming movements.

5. Valuation discrepancies: The claim further questions a billion-dollar valuation given the company reported only $551,970 in franchise fee revenue six months prior to the collapse, with just 39 franchisees to its name.

Response from Legal Representatives

Joseph E. Levi, Esq., a lawyer involved in the case, emphasized that vague risk descriptors cannot replace the obligation to disclose known, existing issues affecting securities. He calls attention to how the financial landscape described in the IPO prospectus failed to convey the true volatility and manipulation faced by BYAH shares.

Seeking Investors for Participation

Time is critical for investors that suffered losses during the class period. The lead plaintiff deadline is set for September 28, 2026. Those who experienced financial losses by investing in BYAH within the specified window are encouraged to get in touch for potential class action participation. Contact details for individuals seeking involvement include calling (888) SueWallSt or emailing [email protected].

Next Steps for Shareholders

Investors eligible to participate in this class action are those who have incurred losses, regardless of whether they still hold their shares. Documentation, such as brokerage statements confirming purchase dates and quantities, is needed to substantiate claims and aid eligibility assessment. Moreover, there are no upfront costs associated with pursuing this claim, as this is generally handled on a contingency fee basis.

The BYAH case exemplifies the complexities and risks linked to public company investments, especially where regulatory disclosures may not fully uncover critical underlying problems. Investors are urged to act swiftly to safeguard their rights!